Red Light Therapy During IVF Stimulation: Evidence, Mechanisms and Best Devices

TL;DR

• Red light therapy during IVF stimulation is a supportive tool being used by some fertility clinics and patients, based on its established mechanisms for mitochondrial energy production, oxidative stress reduction, and circulation support.
• The clinical evidence specific to IVF stimulation is early-stage. Most human data comes from small studies and observational reports. Large randomised controlled trials are underway but not yet complete.
• The most relevant human RCT to date applied 850nm near-infrared light transabdominally in women with recurrent implantation failure, finding higher biochemical and clinical pregnancy rates in the treatment group, though differences did not reach statistical significance in the small sample.
• Columbia University has launched the HELIOS Advanced trial (NCT07425080) applying near-infrared light directly to oocytes before fertilisation, measuring blastocyst formation and embryo quality outcomes.
• The main areas of proposed benefit during stims are: oocyte mitochondrial support, reduced oxidative stress from gonadotropin stimulation, improved ovarian blood flow, and endometrial preparation.
• Always discuss red light therapy use during an active IVF cycle with your reproductive endocrinologist before starting.

IVF stimulation places significant metabolic demands on the ovaries. Gonadotropin injections push follicles to develop in numbers and at a pace that would not occur naturally, and this process generates oxidative stress that can affect egg quality. Oocyte mitochondrial function is one of the key determinants of fertilisation success and embryo development, and it is an area where photobiomodulation has well-established biological mechanisms.

Why Oocyte Mitochondria Matter in IVF

Eggs are among the most mitochondria-dense cells in the human body, containing somewhere between 100,000 and 200,000 mitochondria. This is because fertilisation, early cell division, and blastocyst formation all depend on sustained, high-output ATP production at a stage when the embryo cannot yet produce its own energy from glucose.

When oocyte mitochondrial function is compromised, the downstream effects include poor fertilisation rates, arrested embryo development, and reduced blastocyst formation. Age-related fertility decline is partly driven by declining mitochondrial function in eggs. IVF stimulation itself adds oxidative burden: gonadotropins accelerate follicle development at a rate that increases reactive oxygen species in follicular fluid, and high oxidative stress in that fluid is associated with lower oocyte quality. This is the specific biological context in which red and near-infrared light therapy has attracted fertility research interest.

How Red Light Therapy Works: Mechanisms Relevant to IVF

Mitochondrial ATP Production

Red and near-infrared light is absorbed by cytochrome c oxidase in the mitochondrial electron transport chain, increasing electron transport efficiency and driving higher ATP output. In oocytes, more available ATP supports chromosome segregation during meiosis, cortical granule distribution, and the energy demands of early embryo cleavage. The 630 to 660nm and 810 to 850nm ranges are most studied for this effect. The 1060 to 1064nm range penetrates more deeply into pelvic tissue.

Oxidative Stress Reduction

Photobiomodulation upregulates endogenous antioxidant systems including superoxide dismutase and catalase, reducing reactive oxygen species in treated tissue. During ovarian stimulation, this may help protect follicular microenvironments from the elevated oxidative load that gonadotropin-driven stimulation generates. Animal studies have reported reduced oxidative stress markers in follicular fluid following photobiomodulation.

Blood Flow and Ovarian Perfusion

Near-infrared light stimulates nitric oxide release, causing local vasodilation and improving microcirculation. Ovarian blood flow is a recognised predictor of follicle response and oocyte quality in IVF cycles. Improved perfusion during the stimulation phase may support follicular development and nutrient delivery to developing eggs.

Endometrial Support

Some practitioners apply red light therapy over the lower abdomen during stimulation to also support endometrial development. An observational study reported increased endometrial thickness during the luteal phase in women using photobiomodulation, a secondary potential benefit relevant given that thin endometrium is a common cause of failed transfers.

What the Human Evidence Actually Shows

RCT in Recurrent Implantation Failure (Tehran, 2024)

The most methodologically rigorous human study to date applied 850nm near-infrared light transabdominally in a single-blinded RCT of 30 women with recurrent implantation failure. Six 16-minute sessions were given on cycle days 2, 4, 6, 8, 10, and 12 in the cycle before frozen embryo transfer. Biochemical pregnancy rates were 46.7% in the treatment group versus 33.3% in controls. Clinical pregnancy rates were 33.3% versus 20%. Neither difference reached statistical significance, which the authors attributed to small sample size. No side effects were reported. The authors concluded that larger trials are needed.

Pilot Data in Diminished Ovarian Reserve

A pilot study in women with diminished ovarian reserve reported a modest increase in the number of mature oocytes retrieved compared with historical controls following photobiomodulation applied before and during stimulation. This study was not randomised and relied on comparison with prior cycles rather than a concurrent control group, so it is hypothesis-generating rather than conclusive.

The HELIOS Research Programme (Columbia University)

The most significant development in this area is Columbia University's HELIOS research programme, led by Professor Zev Williams. Preclinical studies in mouse and donated human embryos found that targeted near-infrared doses may improve progression to the blastocyst stage without adverse effects. The HELIOS Advanced trial (NCT07425080) has since launched, applying near-infrared light to human oocytes before fertilisation and comparing blastocyst formation rates and embryo quality in sibling embryos from the same stimulation cycle. This trial delivers controlled doses in a clinical embryology setting, distinct from at-home panel use. Its results will provide the most rigorous evidence yet on whether photobiomodulation at the gamete level improves IVF outcomes.

During Stims vs Before and After: When to Use Red Light Therapy

Before Stimulation: Pre-Cycle Preparation

The period before an IVF cycle begins is the lowest-risk window and may be the most strategically useful. Oocyte quality is determined over the 90 days of follicular development preceding retrieval. Using red and near-infrared light consistently in the weeks and months before a cycle begins may support mitochondrial function and reduce oxidative stress during the follicle growth phase that determines egg quality at retrieval. This pre-cycle use carries no risk of interfering with the stimulation protocol.

During Stimulation: Cautious Use With Clinician Guidance

Some practitioners recommend continuing during the stimulation phase, targeting the lower abdomen over the ovarian region. The proposed benefits are continued oxidative stress reduction and blood flow support during high gonadotropin-driven metabolic demand. However, this is when the ovaries are most active and follicle development is being carefully monitored. Any intervention that could affect follicle growth or ovarian response needs to be discussed with your reproductive endocrinologist before use. Use standard session lengths and distances rather than extended sessions during this phase.

After Retrieval and During the Transfer Cycle

After egg retrieval, the focus shifts to endometrial preparation. Red light therapy applied over the lower abdomen during the luteal support phase is used by some patients to support endometrial receptivity and reduce uterine inflammation. The risks at this stage are lower than during active stimulation, though any use during the two-week wait after transfer should be discussed with your fertility team.

StreamShop Devices for IVF and Fertility Support

The devices below are not medical treatments for infertility and are not intended to replace or supplement IVF protocols without guidance from your reproductive endocrinologist. They are red and near-infrared light therapy devices used by people wanting to support their cellular health during the IVF journey.

1064nm Laser Belt ($299.99)

StreamShop's 1064nm laser belt wraps directly around the lower abdomen to deliver 660nm, 850nm, and 1064nm VCSEL laser light hands-free to the pelvic region. For IVF patients, the belt format provides direct, sustained coverage of the ovarian and uterine area without requiring the user to hold a device. The 1064nm laser penetrates more deeply than standard LED panels, relevant given the depth at which the ovaries sit within the pelvis.

LED Light Therapy Dome With 1064nm ($399.99)

StreamShop's LED light therapy dome with 1064nm delivers 660nm, 850nm, and 1064nm across 240 triple-chip LEDs at 87.4 mW/cm2. While designed for facial and head use, the arch format can be positioned over the lower abdomen in a reclining position for hands-free pelvic coverage, making it a flexible option for IVF patients who also want facial skin support.

SS100 Red Light Panel With 1060nm ($749.99)

StreamShop's SS100 red light panel with 1060nm delivers nine wavelengths including 660nm, 810nm, 830nm, 850nm, and 1060nm at 160 mW/cm2 or above through 72 dual-chip LEDs with a 30-degree focusing lens. As an ARTG-listed class IIa medical grade device, it carries the highest regulatory classification of any StreamShop panel. The 810nm and 850nm wavelengths align directly with the range used in the Tehran RCT on recurrent implantation failure. Per-wavelength dimming allows precise protocol configuration.

SS200 Red Light Panel With 1060nm ($1,199.99)

StreamShop's SS200 red light panel with 1060nm delivers the same nine-wavelength configuration as the SS100 across a larger treatment surface. For IVF patients who want to cover both the lower abdomen and lower back in a single session, the SS200's larger format reduces repositioning. The same per-wavelength dimming and medical grade specifications apply.

Red Light Therapy Laser Mat With 1064nm

StreamShop's red light therapy laser mat with 1064nm combines LED and VCSEL laser technology across six wavelengths including 660nm, 830nm, 850nm, 940nm, and 1064nm at 120 mW/cm2 over a 1.8m x 80cm surface. For IVF patients who want full-body coverage, the mat allows lying directly on the device for simultaneous treatment of the full torso and lower body. The 1064nm VCSEL laser provides the deepest penetration of any at-home format.

Frequently Asked Questions

Is Red Light Therapy Safe During IVF Stimulation?

There are no reports of harm from at-home red and near-infrared light therapy during IVF stimulation in the published literature. The concern most practitioners flag is theoretical: aggressive use could potentially affect follicle development during a carefully managed phase of ovarian stimulation. Discuss with your reproductive endocrinologist before using during an active cycle, and use standard session lengths and distances.

Can Red Light Therapy Improve Egg Quality?

The mechanistic rationale is strong: photobiomodulation improves mitochondrial ATP production and reduces oxidative stress, both directly relevant to oocyte quality. Animal studies support this. Human clinical trial data specific to egg quality is early-stage, with the most rigorous human trial (Columbia's HELIOS Advanced) currently recruiting. The honest position is: mechanisms are plausible and preclinically supported, and human trial data is pending.

When Is the Best Time to Use Red Light Therapy During an IVF Cycle?

The pre-cycle window (weeks and months before stimulation begins) is the lowest-risk and potentially highest-impact period, as oocyte quality is determined during the follicle growth phase that precedes stimulation. During stimulation, cautious use with clinician guidance is appropriate. After retrieval, lower-abdomen application to support endometrial receptivity is used by some patients during the transfer cycle.

What Wavelength Is Best for Fertility and IVF?

The Tehran RCT used 850nm. For pelvic organ depth, wavelengths above 800nm and especially 1060 to 1064nm penetrate more deeply than 660nm red light. Devices combining multiple wavelengths provide coverage across the full photobiomodulation spectrum relevant to both surface and deeper pelvic tissue.

What Does the HELIOS Trial Mean for IVF Patients?

The HELIOS Advanced trial applies near-infrared light directly to eggs in the IVF lab before fertilisation, using equipment not available in home settings. If the trial shows improved blastocyst rates, it will not mean that at-home panels produce the same effect, since the lab setting allows precise dosing directly to oocytes. However, it will confirm that photobiomodulation at the gamete level has measurable effects on embryo development, strengthening the mechanistic case for supportive at-home use in the pre-cycle and peri-stimulation window.